Page last updated: 2024-10-27

fluoxetine and Brain Thrombosis

fluoxetine has been researched along with Brain Thrombosis in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brunkhorst, R1
Friedlaender, F1
Ferreirós, N1
Schwalm, S1
Koch, A1
Grammatikos, G1
Toennes, S1
Foerch, C1
Pfeilschifter, J1
Pfeilschifter, W1

Other Studies

1 other study available for fluoxetine and Brain Thrombosis

ArticleYear
Alterations of the Ceramide Metabolism in the Peri-Infarct Cortex Are Independent of the Sphingomyelinase Pathway and Not Influenced by the Acid Sphingomyelinase Inhibitor Fluoxetine.
    Neural plasticity, 2015, Volume: 2015

    Topics: Animals; Ceramides; Cerebral Cortex; Cerebral Infarction; Enzyme Inhibitors; Fluoxetine; Intracrania

2015